scholarly journals Medical device innovations for cardiovascular, ophthalmologic and otolaryngologic applications

2019 ◽  
Vol 5 (1) ◽  
pp. 117-118
Author(s):  
Niels Grabow ◽  
Volkmar Senz ◽  
Klaus-Peter Schmitz

AbstractThe consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 - Partnership for Innovation”, 2014-2021. RESPONSE gives its partners opportunities to put medical device innovations into practice more efficiently. In order to accelerate innovation processes, joint efforts are being made along the entire translation chain. RESPONSE is focusing on the development of novel concepts of implantable medical devices for cardiovascular, ophthalmologic and ENT application. Platform technology approaches are being used to extend the range of device applications. See also: www.response.uni-rostock.de

2020 ◽  
Vol 6 (3) ◽  
pp. 85-86
Author(s):  
Niels Grabow ◽  
Volkmar Senz ◽  
Klaus-Peter Schmitz

AbstractThe consortium RESPONSE is a cooperation of partners from science and industry within the BMBFProgram “Twenty20 - Partnership for Innovation”, 2014- 2021. Current efforts are being made towards the transfer of new products, technologies and processes in the field of medical devices. Here, RESPONSE is focusing on novel concepts of implantable medical devices for cardiovascular, ophthalmologic and otolaryngologic application. Platform technology approaches, such as drug delivery systems for responsive functionalized implants or smart implant technologies, are being used to enable new applications.


2019 ◽  
Vol 117 (1) ◽  
pp. 214-220 ◽  
Author(s):  
Eli J. Curry ◽  
Thinh T. Le ◽  
Ritopa Das ◽  
Kai Ke ◽  
Elise M. Santorella ◽  
...  

Piezoelectric materials, a type of “smart” material that generates electricity while deforming and vice versa, have been used extensively for many important implantable medical devices such as sensors, transducers, and actuators. However, commonly utilized piezoelectric materials are either toxic or nondegradable. Thus, implanted devices employing these materials raise a significant concern in terms of safety issues and often require an invasive removal surgery, which can damage directly interfaced tissues/organs. Here, we present a strategy for materials processing, device assembly, and electronic integration to 1) create biodegradable and biocompatible piezoelectric PLLA [poly(l-lactic acid)] nanofibers with a highly controllable, efficient, and stable piezoelectric performance, and 2) demonstrate device applications of this nanomaterial, including a highly sensitive biodegradable pressure sensor for monitoring vital physiological pressures and a biodegradable ultrasonic transducer for blood–brain barrier opening that can be used to facilitate the delivery of drugs into the brain. These significant applications, which have not been achieved so far by conventional piezoelectric materials and bulk piezoelectric PLLA, demonstrate the PLLA nanofibers as a powerful material platform that offers a profound impact on various medical fields including drug delivery, tissue engineering, and implanted medical devices.


2020 ◽  
Vol 10 (8) ◽  
pp. 2923 ◽  
Author(s):  
Jean-Pierre Alcaraz ◽  
Gauthier Menassol ◽  
Géraldine Penven ◽  
Jacques Thélu ◽  
Sarra El Ichi ◽  
...  

We discuss the perspectives of designing implantable medical devices that have the criterion of being symbiotic. Our starting point was whether the implanted device is intended to have any two-way (“duplex”) communication of energy or materials with the body. Such duplex communication extends the existing concepts of a biomaterial and biocompatibility to include the notion that it is important to consider the intended functional use of the implanted medical device. This demands a biomimetic approach to design functional symbiotic implantable medical devices that can be more efficient in mimicking what is happening at the molecular and cellular levels to create stable interfaces that allow for the unfettered exchanges of molecules between an implanted device and a body. Such a duplex level of communication is considered to be a necessary characteristic of symbiotic implanted medical devices that are designed to function for long periods of time inside the body to restore and assist the function of the body. We illustrate these perspectives with experience gained from implanting functional enzymatic biofuel cells.


2005 ◽  
Vol 12 (1) ◽  
Author(s):  
John Wilkinson

The European Commission has launched a public consultation on its proposed amendments to the Medical Devices Directive (MDD) (Dir 93/42/EEC). The aim of the European Commission's proposals is to improve the coherence, transparency and effectiveness of the legislation governing medical devices in line with the recommendations of the report produced in 2002 by the European Commission's Medical Device Experts Group. This report recommended that the requirements for clinical evaluation of medical devices be clarified, transparency be increased by amending post-market surveillance requirements and that the decision making process be improved by empowering the European Commission to make binding decisions where individual national opinions differ on whether a product falls within the definition of 'medical device'. The report also recommended that the three directives governing medical devices (the MDD, the Active Implantable Medical Devices (AIMD) Directive 90/385/EEC and the In-vitro Medical Devices (IVDD) Directive 98/79/EC) should be made more consistent with each other.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
A Baretta ◽  
R Bursi ◽  
A Palazzin ◽  
L Emili

Abstract Introduction The absorption of radiofrequency (RF) energy during an MRI procedure may cause tissue heating in the vicinity of an implanted device, such as a stent or a stented valve, potentially causing patient harm. Computational modeling and simulation (M&S) can be used by medical device manufacturers to assess the RF-induced heating of implanted devices during an MRI scan and identify worst-case configurations within a given line of implants. However, despite the use of in-silico tools, a standard for in-silico testing of such problematic is still missing; The tool here proposed is a web-based application that automates the set-up and solution of RF-heating analysis, in line with existing standards for in-vitro testing. Methods The presented tool is part of a commercial web-based platform. The tool was developed in collaboration with the market leader of computer-aided engineering software and as part of a Research Collaboration Agreement with the American regulatory body. Commercial software was used to compute RF energy absorption and thermal heating of implantable medical devices replicating the directives of the ASTM F2182–11a Standard Test Method. The model is integrated in an automated workflow. Each simulation submitted by the user is sent to the cloud infrastructure for solution. Simulation results are stored in a database for later retrieval and report generation. Results The tool consists of a web-interface where the user can: i) upload the medical device computer-aided design (CAD) or select a simplified geometry from a library; ii) define the material properties of the device; ii) specify the desired input parameters specific to an MRI exposure scenario. Specifically, it is possible to study the device exposure: i) at different field frequencies (i.e., 64 MHz and 128 MHz); ii) at different powers (i.e., 2, 4 and 10 W/kg Whole body Specific Absorption Rate - SAR); iii) at different field polarizations (i.e., two circular and two linear); and iv) for different exposure time (i.e., form 240 s to 900 s). The presented tool allows the users to view and export results for each simulation, including electromagnetic fields, local SAR, and the temperature rise over time. Finally, the simulation results are summarized in an automatically generated report that follows regulatory guidance on M&S reporting. Conclusion The presented web-based M&S tool allows users to perform the thermal safety assessment of implantable medical devices during an MRI procedure following established good simulation practices. Minimal training or background in computer modeling is required to use the tool. Specific potential applications of the tool include RF-heating assessment of cardiovascular devices (e.g., stents, stented valves, stent retrievers). The proposed platform promotes the broader adoption of digital evidence in preclinical trials for RF safety analysis, supporting the device submission process and pre-market regulatory evaluation. Stent safety simulation result interface Funding Acknowledgement Type of funding source: None


2018 ◽  
Vol 4 (1) ◽  
pp. 653-656 ◽  
Author(s):  
Marcel Vila Wagner ◽  
Thomas Schanze

AbstractFor known reasons, the European Parliament was forced not only to revise the old Medical Device Directive (MDD) and the Active Implantable Medical Devices Directive (AIMDD), but to replace it with the extensive MDR. With the implementation of the Medical Device Regulation (MDR) in May 2017, manufacturers of medical devices will face new challenges for their products in the future, which also have to be implemented in a timely manner. Particularly small and medium-sized enterprises (SMEs) are concerned about whether a timely adaptation to the MDR and their requirements can be implemented. The conversion is associated with a huge effort for all producers of medical devices and certainly, produkt launchers. The purpose of this paper is to get an overview of the most relevant and emerging requirements that manufacturers need to adapt to sell their medical devices in compliance with the MDR regulations. It also explains the extent to which changes and innovations in the MDR are discusses and problems for SMEs.


2018 ◽  
Vol 4 (1) ◽  
pp. 87-88
Author(s):  
Niels Grabow ◽  
Klaus-Peter Schmitz

AbstractMedical device innovations may contribute to the reconstruction of biological functions, and thereby improve the quality of patients’ lives, as well as extend their life expectancy. The coordinated research project “RESPONSE - Partnership for Innovation in Implant Technology” (BMBF program Twenty20 - Partnership for Innovation, 2014 - 2021) is focusing on the development of novel concepts for implantable medical devices for cardiovascular, ophthalmologic and otorhinolaryngologic applications. The joint research efforts of academia and industry in the RESPONSE consortium address the challenges in implant design, biofunctionalization, process development and production. Particular attention is paid to the process of translation of medical device innovations, cost analysis, as well as health technology assessment.


Author(s):  
John Wilkinson ◽  
Andy Crosbie

AbstractRegistries are powerful tools to support manufacturers in the fulfilment of their obligations to perform post-market surveillance and post-market clinical follow-up of implantable medical devices. They are also a valuable resource for regulators in support of regulatory action as well as in providing information around the safety of new and innovative technologies. Registries can provide valuable information on the relative performance of both generic types and manufacturer’s individual products and they complement other sources of information about device performance such as post-market clinical studies and adverse incident reporting. This paper describes the experience of the UK medical device regulator – the Medicines and Healthcare Products Regulatory Agency (MHRA) – of working with registries to monitor the safety and performance of medical devices. Based upon this experience, the authors identify a number of attributes for a registry which they consider to be key if the registry is to contribute effectively to the work of regulators on patient safety monitoring and medical device regulation.


2017 ◽  
Vol 137 (6) ◽  
pp. 152-158
Author(s):  
Satoshi Inoue ◽  
Takuya Takahashi ◽  
Momoko Kumemura ◽  
Kazunori Ishibashi ◽  
Hiroyuki Fujita ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document